Inventor · disambiguated record
Klaus Eistetter
Also filed as: EISTETTER KLAUS
16 granted patents·10 pending applications·224 citations·filing 1977–2015
94Inventor score
Top patents by PatentIndex Score
26 records- 0187US4337267APhenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing themBYK GULDEN LOMBERG CHEM FAB·Filed 1981·Granted Jun 29, 1982·25 cites·13 claims
- 0286US7951397B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientNYCOMED GMBH·Filed 2003·Granted May 31, 2011·13 cites·33 claims
- 0386US4430339ASubstituted oxiranecarboxylic acids, their preparation and their use as medicamentsBYK GULDEN LOMBERG CHEM FAB·Filed 1981·Granted Feb 7, 1984·19 cites·13 claims
- 0485US8431154B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipientDIETRICH RANGO·Filed 2011·Granted Apr 30, 2013·5 cites·38 claims
- 0584US9713682B2Device for dosing and dry nebulizationEISTETTER KLAUS·Filed 2006·Granted Jul 25, 2017·21 cites·15 claims
- 0680US4333942AAnti-depressant and analgesic 4-phenoxypiperidinesBYK GULDEN LOMBERG CHEM FAB·Filed 1980·Granted Jun 8, 1982·23 cites·28 claims
- 0779US6315983B1Process for the production of powdered pulmonary surfactant preparationsBYK GULDEN LOMBERG CHEM FAB·Filed 1997·Granted Nov 13, 2001·46 cites·18 claims
- 0875US4324796ASubstituted oxiranecarboxylic acids, their use and medicaments containing themBYK GULDEN LOMBERG CHEM FAB·Filed 1980·Granted Apr 13, 1982·16 cites·21 claims
- 0969US4221788A2-(Optionally-substituted)benzylperhydroazepines for analgesia and lowering blood pressureBYK GULDEN LOMBERG CHEM FAB·Filed 1977·Granted Sep 9, 1980·6 cites·47 claims
- 1068US4946866AUse of oxirancarboxylic acids for the treatment of hyperlipemiaBYK GULDEN LOMBERG CHEM FAB·Filed 1987·Granted Aug 7, 1990·14 cites·17 claims
- 1166US9468598B2Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientASTRAZENECA AB·Filed 2013·Granted Oct 18, 2016·0 cites·41 claims
- 1265US6436970B1Compositions for the treatment of ARDS or IRDS containing 3-(cycloproplymethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactantBYK GULDEN LOMBERG CHEM FAB·Filed 1999·Granted Aug 20, 2002·19 cites·11 claims
- 1365US2014031396A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientTAKEDA GMBH·Filed 2013·Application pending·0 cites
- 1465US2014031397A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientTAKEDA GMBH·Filed 2013·Application pending·0 cites
- 1564US4279918A2-(Nuclearly-substituted)benzylpyrrolidinesBYK GULDEN LOMBERG CHEM FAB·Filed 1977·Granted Jul 21, 1981·9 cites·36 claims
- 1663US2006269600A1Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientALTANA PHARMA AG·Filed 2006·Application pending·0 cites
- 1763US2013131123A1Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientDIETRICH RANGO·Filed 2013·Application pending·0 cites
- 1862US6998410B2CompositionsALTANA PHARMA AG·Filed 2002·Granted Feb 14, 2006·1 cites·7 claims
- 1962US4395414ASubstituted quinolinone-alkanecarboxylic acids and medicaments containing them, having a hyperglycaemic actionBYK GULDEN LOMBERG CHEM FAB·Filed 1981·Granted Jul 26, 1983·5 cites·8 claims
- 2060US2015290179A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 2160US2015290180A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 2260US2015290178A1Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as ExcipientTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 2359US2011060016A1Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientNYCOMED GMBH·Filed 2010·Application pending·0 cites
- 2442US4198424ASubstituted 1-phenyl-2-pyrrolidin-2-yl-ethanols, their synthesis, their use and their compositionsBYK GULDEN LOMBERG CHEM FAB·Filed 1978·Granted Apr 15, 1980·2 cites·22 claims
- 2538US2006211668A1Use of ciclesonide for the treatment of inflammatory bowel diseasesALTANA PHARMA AG·Filed 2004·Application pending·0 cites
- 2637US2009011978A1Use of Surfactant Preparations for the Treatment of Surgical AdhesionsATLANTA PHARMA AG·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →